These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 34893458)
1. Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial. Fonteyne V; Dirix P; Van Praet C; Berghen C; Albersen M; Junius S; Liefhooghe N; Noé L; De Meerleer G; Ost P; Villeirs G; Verbeke S; De Maeseneer D; Rammant E; Verghote F; Elhaseen E; De Man K; Decaestecker K Eur Urol Focus; 2022 Sep; 8(5):1238-1245. PubMed ID: 34893458 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial. Fonteyne V; Dirix P; Junius S; Rammant E; Ost P; De Meerleer G; Swimberghe M; Decaestecker K BMC Cancer; 2017 May; 17(1):308. PubMed ID: 28464906 [TBL] [Abstract][Full Text] [Related]
3. Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer. Murthy V; Maitre P; Singh M; Pal M; Arora A; Pujari L; Kapoor A; Pandey H; Sharma R; Gudipudi D; Joshi A; Prabhash K; Noronha V; Menon S; Mehta P; Bakshi G; Prakash G Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e506-e515. PubMed ID: 37208232 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study. Orré M; Latorzeff I; Fléchon A; Roubaud G; Brouste V; Gaston R; Piéchaud T; Richaud P; Chapet O; Sargos P PLoS One; 2017; 12(4):e0174978. PubMed ID: 28384195 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
6. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013. Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy. Sargos P; Baumann BC; Eapen L; Christodouleas J; Bahl A; Murthy V; Efstathiou J; Fonteyne V; Ballas L; Zaghloul M; Roubaud G; Orré M; Larré S Cancer Treat Rev; 2018 Nov; 70():88-97. PubMed ID: 30125800 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer. Solanki AA; Martin B; Korpics M; Small C; Harkenrider MM; Mitin T Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):429-435. PubMed ID: 28242163 [TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies. Zhang M; Tao R; Zhang C; Shen Z Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial. Zaghloul MS; Christodouleas JP; Smith A; Abdallah A; William H; Khaled HM; Hwang WT; Baumann BC JAMA Surg; 2018 Jan; 153(1):e174591. PubMed ID: 29188298 [TBL] [Abstract][Full Text] [Related]
11. Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancer. Navarro-Domenech I; Arulanantham S; Liu ZA; Tjong M; Kong V; Malkov V; Tadic T; Fleshner N; Kulkarni G; Zlotta AR; Catton C; Berlin A; Sridhar S; Jiang DM; Chung P; Raman S Radiat Oncol; 2023 Sep; 18(1):154. PubMed ID: 37730609 [TBL] [Abstract][Full Text] [Related]
12. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials. Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838 [TBL] [Abstract][Full Text] [Related]
13. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. Mir MC; Marchioni M; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; McGrath JS; Kassouf W; Dall'Era MA; Sridhar SS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand D; Black PC Eur Urol Focus; 2021 Nov; 7(6):1347-1354. PubMed ID: 32771446 [TBL] [Abstract][Full Text] [Related]
14. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences. Startsev VY Arch Ital Urol Androl; 2002 Jun; 74(2):54-6. PubMed ID: 12161935 [TBL] [Abstract][Full Text] [Related]
15. Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial. Hall E; Hussain SA; Porta N; Lewis R; Crundwell M; Jenkins P; Rawlings C; Tremlett J; Sreenivasan T; Wallace J; Syndikus I; Sheehan D; Lydon A; Huddart R; James N; Eur Urol; 2022 Sep; 82(3):273-279. PubMed ID: 35577644 [TBL] [Abstract][Full Text] [Related]
16. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy. Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956 [TBL] [Abstract][Full Text] [Related]
17. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy. Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837 [TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764 [TBL] [Abstract][Full Text] [Related]
19. Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder. Szabados B; Kockx M; Assaf ZJ; van Dam PJ; Rodriguez-Vida A; Duran I; Crabb SJ; Van Der Heijden MS; Pous AF; Gravis G; Herranz UA; Protheroe A; Ravaud A; Maillet D; Mendez MJ; Suarez C; Linch M; Prendergast A; Tyson C; Stanoeva D; Daelemans S; Rombouts M; Mariathasan S; Tea JS; Mousa K; Sharma S; Aleshin A; Banchereau R; Castellano D; Powles T Eur Urol; 2022 Aug; 82(2):212-222. PubMed ID: 35577646 [TBL] [Abstract][Full Text] [Related]
20. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]